Sulfuric Acid

Sulfuric Acid

SCHEMBL379146

C=Cc1ccccc1C=O.O=S(=O)(O)O

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.56
LMNA P02545 2/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
THRB P10828 1/20 0.56
BLM P54132 1/20 0.56
TRIM24 O15164 1/20 0.46
TRIM33 Q9UPN9 1/20 0.46
ALDH1A1 P00352 4/20 0.41
TSHR P16473 1/20 0.41
ERN1 O75460 2/20 0.39
PADI4 Q9UM07 1/20 0.38
HPGD P15428 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SRC P12931 1/20 0.37
CYP2A6 P11509 2/20 0.35
GAA P10253 1/20 0.35
IMPDH2 P12268 1/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL968452 0.91 ALDH1A1 (0.48) TDP1LMNAKMT2AMEN1THRB
SCHEMBL23559 0.89 LMNA (0.72) TDP1LMNAKMT2AMEN1THRB
Ethylene Glycol SCHEMBL28223913 0.83 LMNA (0.56) TDP1LMNAKMT2AMEN1THRB
Vinylsulfonic Acid SCHEMBL28173703 0.82 TDP1 (0.45) TDP1LMNAKMT2AMEN1THRB
Styrene SCHEMBL8087550 0.81 ALDH1A1 (0.58) TDP1LMNAKMT2AMEN1ALDH1A1
Vinylsulfonic Acid SCHEMBL28148853 0.80 TDP1 (0.43) TDP1LMNAKMT2AMEN1THRB
Formic Acid SCHEMBL28194049 0.79 ALDH1A1 (0.50) TDP1LMNAKMT2AMEN1THRB
Styrene SCHEMBL8168630 0.78 ALDH1A1 (0.61) TDP1LMNAKMT2AMEN1THRB
Sulfuric Acid SCHEMBL8445673 0.78 TRIM24 (0.52) LMNAKMT2AMEN1TRIM24TRIM33
Sulfuric Acid SCHEMBL3091932 0.78 ACHE (0.49) LMNAKMT2AMEN1ALDH1A1ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106232092-B Antimicrobial compositions containing cationic active ingredients 艺康美国股份有限公司 2020-07-14 CN claimed
US-10159246-B2 Copolymers of N-vinylcarboxamide and diallyldialkylammonium salt as dispersant for agrochemical formulations BASF SE (DE) 2018-12-25 US claimed
EP-2109441-B1 POLYSILOXANE BLOCK COPOLYMERS BASF SE (DE) 2016-01-27 EP claimed
EP-2713720-B1 COPOLYMERS OF N-VINYLCARBOXAMIDE AND DIALLYLDIALKYLAMMONIUM SALT AS DISPERSANT FOR AGROCHEMICAL FORMULATIONS BASF SE (DE) 2016-01-06 EP claimed
US-20140080702-A1 Copolymers of N-vinylcarboxamide and diallyldialkylammonium salt as dispersant for agrochemical formulations BASF SE (DE) 2014-03-20 US claimed
EP-2163553-B1 ARENE CONNECTED POLYAMINE MACRORING DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO LTD (CN) 2013-12-25 EP claimed
US-8450353-B2 Topical compositions containing desthiobiotin and its derivatives and a method of treating skin AVON PRODUCTS, INC. (US) 2013-05-28 US claimed
US-8420626-B2 Arene connected polyamine macrocyclic derivatives, preparation methods and pharmaceutical uses thereof BEIJING MOLECULE SCIENCE AND TECHNOLOGY CO., LTD. (CN) 2013-04-16 US claimed
US-20130012430-A1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-10 US claimed
US-20130005739-A1 PHARMACEUTICAL PREPARATIONS COMPRISING A COS RELEASING COMPOUND LUDWIG BOLTZMANN CLUSTER FUER KARDIOVASKULAERE FORSCHUNG (AT) 2013-01-03 US claimed
US-20050261419-A1 High molecular weight cationic polymers obtained by post-polymerization crosslinking reaction SONG ZHIQIANG 2005-11-24 US claimed
EP-1539827-A1 HIGH MOLECULAR WEIGHT CATIONIC POLYMERS OBTAINED BY POST-POLYMERISATION CROSSLINKING REACTION Ciba Specialty Chemicals Water Treatments Limited (GB) 2005-06-15 EP claimed
WO-2004101882-A1 USE OF WATER-SOLUBLE CROSSLINKED CATIONIC POLYMERS FOR CONTROLLING DEPOSITION OF PITCH AND STICKIES IN PAPERMAKING CIBA SPECIALTY CHEMICALS WATER TREATMENTS LIMITED (GB) 2004-11-25 WO claimed
US-20040226676-A1 Use of water-soluble crosslinked cationic polymers for controlling deposition of pitch and stickies in papermaking CIBA SPECIALTY CHEMICALS WATER TREATMENTS LIMITED (GB) 2004-11-18 US claimed
WO-2004050701-A1 BONE GROWTH FACTOR OSTEOPHARM INC. (CA) 2004-06-17 WO claimed
WO-2004018524-A1 HIGH MOLECULAR WEIGHT CATIONIC POLYMERS OBTAINED BY POST-POLYMERISATION CROSSLINKING REACTION CIBA SPECIALTY CHEMICALS WATER TREATMENTS LIMITED (GB) 2004-03-04 WO claimed
US-20040034156-A1 High molecular weight cationic polymers obtained by post-polymerization crosslinking reaction CIBA SPECIALTY CHEMICALS WATER TREATMENTS LIMITED (GB) 2004-02-19 US claimed
US-20030232800-A1 Non-symmetric tripyrranes in the synthesis of novel macrocycles UNIVERSITY OF TEXAS 2003-12-18 US claimed
WO-2002017925-A1 NON-SYMMETRIC TRIPYRRANNES IN THE SYNTHESIS OF NOVEL MACROCYCLES PHARMACYCLICS, INC. (US) 2002-03-07 WO claimed
US-4395402-A ENKEPHALIN IN HIBITOR, SYNERGISTIC COMPOUND WITH MORPHINE ZAIDAN HOJIN BISEIBUTSU KAGAKU KANKYU KAI (JP) 1983-07-26 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140080702-A1 Copolymers of N-vinylcarboxamide and diallyldialkylammonium salt as dispersant for agrochemical formulations DDT, CDIPT, ACMSD TDP1 2709/4885LMNA 4232/4885KMT2A 416/4885
US-10159246-B2 Copolymers of N-vinylcarboxamide and diallyldialkylammonium salt as dispersant for agrochemical formulations DDT, CDIPT, ACMSD TDP1 2709/4885LMNA 4232/4885KMT2A 416/4885
US-20130012430-A1 INHIBITORS OF SERINE PROTEASES, PARTICULARLY HEPATITIS C VIRUS NS3 PROTEASE HPN, PRSS1, PRSS3 TDP1 2733/4885LMNA 2150/4885KMT2A 3959/4885
US-20130005739-A1 PHARMACEUTICAL PREPARATIONS COMPRISING A COS RELEASING COMPOUND VIP, CRH, ADCYAP1R1 TDP1 2484/4885LMNA 1473/4885KMT2A 4871/4885
US-20030232800-A1 Non-symmetric tripyrranes in the synthesis of novel macrocycles NUP188, TRIP13, NUP160 TDP1 1284/4885LMNA 2222/4885KMT2A 4677/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.